Effect of Xuebijing injection on peripheral T-lymphocyte subpopulations in patients with severe trauma / 中华创伤杂志(英文版)
Chinese Journal of Traumatology
;
(6): 72-76, 2010.
Artigo
em Inglês
| WPRIM
| ID: wpr-272945
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the effect and clinical significance of Xuebijing injection on peripheral T-lymphocyte subpopulations in patients with severe trauma.</p><p><b>METHODS</b>Thirty-three patients with severe trauma were randomly divided into a control group (n=16) and a treatment group (n=17). The patients of two groups were all treated conventionally, and the only difference was that Xuebijing injection was given to patients of the treatment group. The CD4+ and CD8+ subpopulations of T-lymphocyte in the peripheral blood were detected respectively on admission, 3rd and 5th days after trauma by double antibody labeling and flow cytometry.</p><p><b>RESULTS</b>The CD4+ T-lymphocytes and CD4+/CD8+ ratio of peripheral blood in patients with severe trauma decreased markedly on the 3rd and 5th days after trauma. Furthermore, compared with control group, the peripheral CD4+ T-lymphocytes and CD4+/CD8+ ratio of treatment group renewed obviously on the 5th day after trauma, and showed statistical differences (P<0.05).</p><p><b>CONCLUSION</b>In the treatment of patients with severe trauma, the early use of Xuebijing injection is effective in correcting disorder or suppression of T-lymphocyte subpopulations regulating network, and promoting a more balanced profile of immunologic function.</p>
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Prognóstico
/
Ferimentos e Lesões
/
Medicamentos de Ervas Chinesas
/
Subpopulações de Linfócitos T
/
Relação CD4-CD8
/
Usos Terapêuticos
/
Tratamento Farmacológico
/
Alergia e Imunologia
/
Injeções
Tipo de estudo:
Estudo prognóstico
Limite:
Adulto
/
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Chinese Journal of Traumatology
Ano de publicação:
2010
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS